The Current Ratio as of September 2024 (TTM) for Freeline Therapeutics Holdings plc (FRLN) is 1.95

According to Freeline Therapeutics Holdings plc’s latest financial reports and current stock price. The company's current Current Ratio is 1.95. This represents a change of -17.14% compared to the average of 2.35 of the last 4 quarters.

Freeline Therapeutics Holdings plc (FRLN) Historical Current Ratio (quarterly & annually)

How has FRLN Current Ratio performed in the past?

The mean historical Current Ratio of Freeline Therapeutics Holdings plc over the last ten years is 6.42. The current 1.95 Current Ratio has changed 2.93% with respect to the historical average. Over the past ten years (40 quarters), FRLN's Current Ratio was at its highest in in the March 2021 quarter at 14.13. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Freeline Therapeutics Holdings plc (FRLN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Freeline Therapeutics Holdings plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Freeline Therapeutics Holdings plc (FRLN) Average Current Ratio

How has FRLN Current Ratio performed in the past?

The current Current Ratio of Freeline Therapeutics Holdings plc (FRLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Freeline Therapeutics Holdings plc (FRLN) Current Ratio vs. Peers

How is FRLN’s Current Ratio compared to its peers?

Freeline Therapeutics Holdings plc’s Current Ratio is greater than CNS Pharmaceuticals, Inc. (0.31), greater than ZyVersa Therapeutics, Inc. (0.06), greater than eFFECTOR Therapeutics, Inc. (1.03), less than VectivBio Holding AG (9.14), less than AVROBIO, Inc. (26.17), less than Immix Biopharma, Inc. (7.00), less than Hepion Pharmaceuticals, Inc. (5.62), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65),

Build a custom stock screener for Freeline Therapeutics Holdings plc (FRLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Freeline Therapeutics Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Freeline Therapeutics Holdings plc (FRLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Freeline Therapeutics Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.